ABSTRACT: Introduction: Nebulin is a giant actin-binding protein in the thin filament of the skeletal muscle sarcomere. Studies of nebulin interactions are limited by the size, complexity, and poor solubility of the protein. We divided the nebulin super-repeat region into a super-repeat panel, and studied nebulin/actin interactions. Methods: Actin binding was studied using a co-sedimentation assay with filamentous actin and 26 different nebulin superrepeats. Results: The panel revealed notable differences in actin binding between the super-repeats. Both ends of the superrepeat region bound actin significantly more strongly, whereas the central part of the protein bound actin weakly. Thus, the binding between nebulin and actin formed a location-dependent pattern of strong vs. weak binding. Discussion: The nebulin super-repeat panel allowed us to study the actin binding of each super-repeat individually. The panel will be a powerful tool in elucidating nebulin function in health and disease.
teins known. One nebulin molecule spans nearly the entire length of the thin filament in the skeletal muscle sarcomere. 1 The nebulin gene (NEB) has 183 exons, giving rise to a theoretical full-length mRNA of 26 kb; however, due to extensive alternative splicing, a large number of NEB isoforms exist. 2, 3 Pathogenic variants in NEB are the most common cause of autosomal recessive (AR) nemaline myopathy (NEM2, MIM ID #256030), according to our estimate accounting for approximately 50% of all nemaline myopathy (NM) cases. To date, more than 200 different NM-causing variants have been found dispersed along the entire length of the gene. [4] [5] [6] [7] Variants in NEB have also been found to cause distal nebulin myopathy, 8 distal NM, 9 rare cases of corerod myopathy, 10 and fetal akinesia/lethal multiple pterygium syndrome. 5, 11 Despite the large number of pathogenic variants identified so far, no clear mutational hotspots or distinct genotype-phenotype correlations have been shown to exist. 5 Nebulin has several binding partners, the most important being actin in the thin filament, where nebulin is thought to act as an actin filament stabilizer. Studies on Neb knockout (KO) mouse models 12, 13 demonstrated that the thin filaments can assemble in the absence of nebulin, but, as the muscles start contracting, the filaments begin to disintegrate. Both studies also reported shortened thin filaments, and a similar trend was found in a study on muscle samples from patients with different NEB mutations, 14 suggesting a role for nebulin in specifying the minimum thin filament length. Nebulin has also been thought to regulate the width of the Z-disk, and, through its interaction with desmin, intermyofibrillar connectivity. 15 Many roles have been implicated for nebulin, yet little is known about the functional properties of this enormous protein.
The protein structure of nebulin is highly modular (see FIG. S1 in the Supplementary Material available online). One nebulin molecule has the potential to bind to more than 200 actin monomers with the conserved actin-binding motifs (SDxxYK) present in each simple repeat along the length of the protein. Nebulin super-repeats (SRs), covering most of the protein, consist of 7 simple repeats and harbor a putative tropomyosin (TPM)-binding site (WLKGIGW).
1,2
The SRs are numbered S1-S22 according to the original publication by Labeit and Kolmerer, 1 but the subsequently discovered exons raise the number of different SRs to 26. 2 The alternatively spliced regions result in additional SRs: S11b consisting of the alternatively spliced, grouped exons 63-66, and the 2 forms of S21, depending on whether the alternatively spliced exon 143 or exon 144 is included in the transcript (translating into S21a and S21b, respectively). The triplicate region gives rise to 3 different SRs, in this study named TRI1, TRI2, and TRI3, in place of the original S15. 2 In addition to the modular structure, nebulin has unique end-domains, of which the C-terminus is nestled deep within the Z-disk, and the N-terminus is located near the pointed end of the thin filament.
1,16
Studies on the nebulin protein have been hindered by limitations and technical challenges set by the size, complexity, and poor solubility of the protein. To overcome these problems, we have constructed a nebulin SR panel of minigenes (see FIG. S1 online), covering the entire SR region of the protein.
Herein we present an application of the constructed nebulin SR panel, studying the actinbinding ability of all the various wild-type (WT) SRs along the length of nebulin. Our aim was to reveal any differences between the seemingly similar superrepeats of 7 simple repeats. The binding strength of individual nebulin SR fragments to filamentous actin (F-actin) was assessed using a a co-sedimentation assay.
METHODS
The sequence of the entire NEB SR region was divided into 26 minigenes (see Table S1 online), each corresponding to a unique SR (FIG. S1 online) . Seventeen of the 26 different nebulin SRs were constructed by reverse transcriptionpolymerase chain reaction (RT-PCR) and T-vector cloning (Invitrogen, Thermo Fisher Scientific, Waltham, Massachusetts), 4 SRs were constructed for our previous study, 17 and 5 were synthesized by GenScript (Piscataway, New Jersey). The SR fragments were subsequently cloned into a pGEX-4 T-1 vector and expressed as a fusion protein with an N-terminal glutathione S-transferase (GST) tag in BL21 (DE3) chemically competent cells (Invitrogen). The sizes of the fragments varied from 53.58 to 66.01 kDa (Table S1 online).
Nebulin SR protein expression was induced in the bacterial culture with a concentration of 0.45 mmol/L isopropyl β-D−1 thiogalactopyranoside (IPTG), at a 600-nm optical density (OD 600 ) of 0.5-0.8 at room temperature (RT) for 1.5 hours to overnight (o/n), and the cells were pelleted. Protein extraction was done by sonication in phosphate-buffered saline (PBS) with Pierce Proteinase Inhibitor (Thermo Fisher Scientific), lysozyme with a concentration 0.25 mg/ml (Sigma Aldrich, St. Louis, Missouri), and 0.5% Triton-X 100 (SigmaAldrich). The SR fragments were purified from crude lysates using Protino glutathione agarose 4B beads (Macherey-Nagel, Düren, Germany). The proteins were separated and the yield was visualized on 12% sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels (Bio-Rad, Hercules, California) stained with Coomassie Brilliant Blue (Bio-Rad). The gels were scanned with the Odyssey Imaging System (LI-COR Biosciences, Lincoln, Nebraska).
The nebulin fragments produced were eluted from the beads o/n at +8 C in elution buffer (50 mmol/L Tris-HCl [pH 8 .0] and 10 mmol/L glutathione; Sigma-Aldrich or Acros Organics), with Pierce Proteinase Inhibitor (Thermo Fisher Scientific), according to the glutathione bead manufacturer's protocol (Macherey-Nagel). The SR protein sample (test protein stock) was prepared at the highest possible concentration according to the skeletal muscle actin-binding protein biochem-kit protocol (Actin-Binding Protein SpinDown Assay Biochem Kit [rabbit skeletal muscle actin, #BK001]; Cytoskeleton, Denver, Colorado), by centrifugation at 150,000 g for 1 hour at +4 C (Optima MAX Ultracentrifuge and TLA100.3 rotor; Beckman Coulter, Brea, California), with an additional centrifugation step at 150,000 g for 1 hour at +4 C to confirm purity. Before proceeding to the actin-binding experiment, the yield and quality of each SR protein fragment was confirmed once more by running the purified protein sample on 12% SDS-PAGE gels and staining with Coomassie Brilliant Blue. The identity of the protein band was verified with glutathione-S-transferase-horseradish peroxidase antibody (GST-HRP Ab; Abcam, Cambridge, UK) Western blot.
If the yield was low, the expression culture volume was increased, and the final SR protein sample was concentrated by decreasing the amount of glutathione beads used in the purification step. If the yield remained too low after the concentration steps, the solubility of the fragment was examined by visualizing the separated supernatant and pellet fractions of the crude protein lysates on SDS-PAGE gels. If a sufficient fraction of the protein remained soluble, the sample was used for the actin-binding experiment. The lowest concentration of nebulin successfully used in the binding reaction was 0.22 μmol/L, and the highest concentration achieved was 6.93 μmol/L in the final reaction. The actin-binding experiment was performed according to the actin-binding kit protocol (Cytoskeleton). Ten microliters of the nebulin test protein stock was mixed with 40 μl of F-actin (final concentration 17 μmol/L), allowed to bind for 30 minutes at RT, and centrifuged at 150,000 g for 1.5 hours at 24 C. The pellet (P) and supernatant (S) fractions were separated after centrifugation, and visualized on 12% SDS-PAGE gels stained with Coomassie Brilliant Blue for 1 hour. As a negative control, the nebulin fragments were also tested without actin, alongside the actin-containing binding experiments.
To ensure the specificity of the SR-GST fusion protein binding to F-actin, various concentrations of purified GST tag alone were also tested in the co-sedimentation reaction with F-actin.
The amount of SR fragments in the S and P fractions of each individual experiment were quantified from the gel images, and the values of the intensities of all the S and P pairs were converted into percentages of the total amount using ImageJ software (S fraction + P fraction = 100% in any individual experiment). The mean value of the percentages of the SR fragment found in the P or S fraction, collected from the experiments repeated 5-7 times for a given SR, was presented in a column graph with minimum and maximum values indicated. The quantifications were performed on the bands shown in FIGURE 3, representing the full-length SR based on size.
Statistical analyses were performed using nonparametric one-way analysis of variance (Kruskal-Wallis test) and the Tukey honestly significant difference post-hoc test for the entire data set of WT SR comparisons.
Protein sequence alignment using MUltiple Sequence Comparison by Log-Expectation, that is, MUSCLE (http://www. ebi.ac.uk/Tools/msa/muscle/), was performed to align and organize all the SRs according to the similarity of their sequences. 18 All aligned SR sequences were then submitted into WebLogo 3 (http://weblogo.threeplusone.com/) to generate a sequence logo in which the conserved amino acids are represented by letters of larger size. 19, 20 
RESULTS
All the nebulin fragments used in the F-actin binding experiment were soluble and found in the supernatant fraction in the control reaction, after centrifugation without F-actin (FIG. 1A) . Fractions of the nebulin SR fragments were found co-sedimented in the pellet in the reactions where F-actin was present in excess (FIG. 1A) . The percentage of nebulin SR fragment of the total quantity that co-sedimented with F-actin revealed a pattern of either strong F-actin binding, representing 73%-88% of the total protein, or weak F-actin binding, representing 10%-26% along the SR panel (FIG. 1B, and Table S2 online). GST alone did not bind actin (FIG. 1C) .
The nebulin SR protein sample was prepared at the highest possible concentration. The division into strong or weak binding was clear regardless of the starting concentration or stability of the protein, and in all the reactions F-actin was present in excess compared with the SR fragment. The protein yield and stability of the individual nebulin SRs varied; one of the repeats (S21) was insoluble and had to be excluded. If degradation occurred, quantification was performed on the fragment representing the full-length SR according to size.
The actin binding was low throughout the central part of the nebulin SR region, but both ends (S1-S4 and S22) bound actin considerably stronger. The strongest binding to actin was seen for S22, in which 88% of the SR was found in the pellet fraction. Toward the pointed end of the thin filament, S1 had the strongest binding (78%), with S2, S3, and S4 also binding strongly (76%, 73%, and 74%, respectively). Actin binding dropped to 14% at S5, and continued to vary between 10% (S10) and 26% (S6) along the filament, again dropping down to a weaker binding at S20 (12%) before reaching the strongest binding at S22 (FIG. 1B) . Nonparametric one-way analysis of variance (Kruskal-Wallis test) calculated on the mean values within the entire data set confirmed FIGURE 1. The nebulin super-repeat panel reveals notable differences in actin binding between the various super-repeats. (A) The nebulin super-repeats (NEB-SR), tested without F-actin (−) in the co-sedimentation experiment control, remain in the supernatant (S) fraction. In a reaction with F-actin (+), a fraction of the nebulin SR fragment is found co-sedimented in the pellet (P) with F-actin. The sizes of the fragments vary from 53.58 to 66.01 kDa (see Table S1 Table S2 online). Nonparametric one-way analysis of variance across the entire data set (P < 0.0001), and Tukey post-hoc test between the SRs binding strongly (S1-S4, S22) and weakly (S5-S20) (P < 0.0001). (C) GST and F-actin were tested in control reactions without the nebulin SR fragment to confirm that GST alone did not bind F-actin. (−), reaction without F-actin; (+), reaction with F-actin; S, supernatant fraction; P, pellet fraction; kDa, kilodalton. [Color figure can be viewed at wileyonlinelibrary.com] that this variation was statistically significant (P < 0.0001), and the Tukey post hoc test confirmed that the most significant variation (P < 0.0001) occurred between the SRs binding strongly (S1-S4 and S22) and weakly (S5-S20) to actin.
Most of the S21a and S21b fragments were insoluble, and remained in the bacterial pellet after separation of the protein lysate (not shown). Experiments of S21b binding to actin indicated minor binding, but the result could not be quantified reliably (not shown). After several attempts of concentrating the soluble fraction of the sample, the yield of both S21 fragments remained too low to perform the binding experiment reliably, and thus both S21a and S21b were excluded from the analyses.
Studying the conservation of amino acids between the different SRs in WebLogo highlighted the known actin-and tropomyosin-binding motifs in the combined sequence alignment (FIG. 2A) . In the alignment of all the SRs, varying levels of conservation between the amino acids were seen in the known motifs of the different repeats, and the only 100% conserved amino acid was the tyrosine (Y) in the known actin-binding site (SDxxYK). Comparison of the SRs binding strongly or weakly to actin (FIG. 2B and C) or a more detailed comparison of all the simple repeat sequences (FIG. S2 online) did not reveal notable differences in the actin-binding motifs or the flanking sequences. However, the putative TPMbinding motif (WLKGIGW) in the simple repeat 3 (R3) appeared more conserved in the SRs that bind actin weakly.
DISCUSSION
Our studies have revealed a striking pattern of alternating strong and weak binding to actin, clearly depending on the original location of the SR within the nebulin protein-whether it was toward the ends of the protein, or in the central region (FIG. 3) . We also compared the acquired results with the structure and composition of the different SRs, especially the conserved sequences in the actin-binding sites that all the repeats have in common. However, no clear differences were observed that could explain the differences in binding strength.
In one of the first studies on nebulin fragments, Jin et al. 21 used fragments of 2-15 simple repeats, and confirmed strong actin binding near the Nterminus of the protein. The larger fragments, containing 6-15 simple repeats near the N-terminus, were not soluble under normal pH conditions. Together, their N-terminal fragments covered a part of nebulin before the fourth super-repeat S4, a region we also found binding actin strongly.
Zhang et al. 22 used even longer, mouse-derived nebulin fragments, corresponding to approximately 3 and 4 SRs, respectively, in the central part of the SR region (2 overlapping fragments corresponding to S8-S12 in human nebulin). They found that their constructs bound F-actin with high affinity, but the method and constructs used were different from ours, and the long protein fragments were in an insoluble state before the binding experiment.
Most of our SRs were successfully expressed in adequate concentrations for the binding experiment, with no difficulty in quantifying the result reliably afterward, whereas some SRs were more challenging to express. Some fragments were partially insoluble, but there was enough soluble protein to perform the binding experiment. It is known that the GST fusion tag can act as a chaperone to facilitate protein folding and solubility. 23 Most of the fragments were soluble and suitable for actin-binding co-sedimentation experiments under standard conditions; however, some of the fragments were more prone to degradation, and they had to be used immediately after protein extraction.
Studies with short fragments consisting of different nebulin simple repeats have confirmed that the shortest active unit of the nebulin-actin interaction is the simple repeat, 24 as only a complete simple repeat bound to actin. The simple repeat fragments in the study were from SRs 1, 2, and 4, and were found to bind actin, but with low affinity. Our corresponding SR constructs S1, S2, and S4 (containing all 7 simple repeats) bound actin strongly; however, it has been shown that an SR may influence multiple actin monomers along the F-actin filament, and that different nebulin simple repeats within the same SR may differ in their actin-binding properties. 25, 26 Furthermore, the simple repeats at the corresponding positions in different SRs (R1-R7) show more sequence similarity than the simple repeats within the same SR. 25 It has been hypothesized that the binding is highly co-operational 27 and that, although the contribution of individual simple repeats may be small, when several bind together, their effects are greatly magnified. 25 To elucidate the differences between the SRs and individual simple repeats, we used sequence alignment tools to study the level of conservation in the amino acid sequences. Surprisingly, no clear differences between the actin-binding sites or the flanking sequences were detected in the comparisons between the SRs binding strongly or weakly to actin. Thus, we were not able to find an explanation for the different binding abilities between the repeats. This suggests that several factors may affect the final binding strength, and additional functional tests are needed to study the significance of the minor differences between the sequences. The interactions of the full-length native nebulin are likely to be more complex than the in vitro results indicate, and other parts of nebulin or other interactions may affect the final binding strength between nebulin and actin.
The clear pattern of stronger and weaker actin binding along the length of the thin filament could be an indication of nebulin providing support to the filament via stronger actin binding toward the ends of the filament, while allowing the dynamic processes of the thin filament to take place. The stronger support may be especially important toward the Nterminus of the protein, closer to the pointed end of the thin filament, where actin and myosin overlap in muscle contraction. 28, 29 The sequence comparisons have revealed that the putative TPM-binding site was less conserved in the strong actin-binding SRs. Thus, we are currently using the SR panel to investigate the role of the tropomyosin-troponin complex (TTC) in the actinnebulin interaction. Our preliminary results show that the presence of additional binding factors affect the strength of nebulin-actin interactions (unpublished). It is possible that the initially weaker actin binding in the central part of the filament may be conditional, and regulated by either the TTC interaction or other factors (as suggested by our unpublished data), whereas the actin binding needs to be constitutively strong toward the ends.
The nebulin protein tolerates a substantial number of changes, and it has been calculated that only 7% of all coding variants are pathogenic. 5 According to studies on Neb-KO models, one functional nebulin copy has to be present for the muscle to function, 12,13 regardless of the type or combination of the variants. No clear genotype-phenotype correlation has been observed between the variant type and the severity of the nemaline myopathy, or any other nebulin-related myopathy. 5 Both pathogenic and benign variants have been found scattered along the entire length of NEB, thus no clear mutational hotspots have been identified. 5 Close to 2,500 missense variants in NEB have been listed in ExAC (exac.broadinstitute.org/). Most (76%) are very rare, only found in 1-3 heterozygous carriers. Some of these variants are probably pathogenic, whereas some are benign, but it is impossible to distinguish them from each other without functional data. In particular, the effects of missense variants on protein function have been very difficult to predict. We hypothesized that missense variants affecting the conserved actin-or TPMbinding sites are more likely to be pathogenic, 5 possibly by changing the binding properties of the motif. The preliminary results from our ongoing studies have revealed that a simple amino acid change in one of the actin-binding motifs of an SR displaying strong actin binding is sufficient to weaken the overall actin binding of the SR (unpublished), providing support for this hypothesis. It has also been hypothesized that mismatches on the nebulin actin-binding motif may result in nebulin being more vulnerable to proteolysis. 14 Our binding studies have revealed differences in actin-binding intensities between seemingly similar SRs, all harboring 7 conserved actin-binding motifs. The exact reason for this diverse binding pattern remains to be elucidated, but the differences between the SRs may have implications on the effects of missense variants changing the actin-binding sites in nebulin. This finding emphasizes the importance of studying each variant and its effects on nebulin protein function individually, and in light of the known properties of the corresponding region of the WT protein.
The construction of a complete panel of nebulin SRs has allowed us to study the actin interactions of the enormous protein nebulin, using protein fragments covering the entire SR region. The nebulin panel will be a powerful tool for elucidating nebulin function and the complex pathogenetic mechanisms underlying the different forms of nemaline myopathy and related disorders, ultimately leading to a better understanding of thin filament function in health and disease. It is also likely to become useful in diagnostics for testing the pathogenicity of NEB variants.
